Description

Tefferi et al reported risk in primary myelofibrosis stratified by cytogenetic findings. This can help to identify a patient who may benefit from more aggressive management. The authors are from the Mayo Clinic.


Patient selection: primary myelofibrosis

 

Categories of risk: favorable, unfavorable and very high risk

Favorable risk:

Normal karyotype

Sole 20q−

Sole 13q−

Sole +9

Sole –Y

Sole sex chromosome abnormality

Sole chromosome 1 translocation/duplication

 

Unfavorable risk:

Sole +8

Sole 7q−

Sole translocations not involving chromosome 1

Two abnormalities not including a VHR abnormality

Single/multiple 5q− abnormalities

Complex karyotype without a VHR abnormality

Monosomal karyotype without a VHR abnormality

Sole abnormalities not otherwise classified

 

Very high risk (VHR):

Single/multiple monosomy 7

Single/multiple inv(3)/3q21 abnormalities

Single/multiple i(17q) abnormalities

Single/multiple 12p−/12p11.2 abnormalities

Single/multiple 11q−/11q23 abnormalities

Single/multiple autosomal trisomies other than +8 or +9 (e.g., +21, +19)


To read more or access our algorithms and calculators, please log in or register.